Aa
A
A
Close
Avatar universal
improved hbsag loss to 29.61% by pegintf+nucs 120weeks
http://www.natap.org/2013/EASL/EASL_70.htm

Program Abstract

Aims: To investigate the improved HBsAgresponse in chronic hepatitis B (CHB) patients treated with prolonged peginterferon α-2a combined with nucleos(t)ide analogue.

Methods: One hundred and fifty-two CHB patients treated with peginterferon α-2a plus nucleos(t)ide analogue from Jan 2007 to Sep 2012 were retrospectively investigated. The mean treatment duration was 79 weeks (range 24-120 weeks). Serum HBsAglevels at baseline, week 12, 24, 36, 48, 72, 96 and 120 of treatment were detected

Results: The cumulative HBsAgloss rates of patients treated at 48-week, 96-week and 120-week with peginterferon α-2a plus nucleos(t)ide analogue were 8.55% (13/152), 26.97% (41/152) and 29.61% (45/152), respectively. The time to HBsAgloss was 74.93±27.21 weeks. Most HBsAgloss occurred during week 49-96. The HBsAglevel at week 12 of treatment in 45 patients who obtained HBsAgloss was 1.91±1.27log10IU/mL, which was significantly lower than baseline (3.22±0.82log10IU/mL) (t=5.759, P< 0.01). However, the HBsAglevel at baseline in 107 patients who did not obtain HBsAgloss was 3.57±0.96 log10 IU/mL and HBsAglevels reduction at week 12, 24, 48, 96 and 120 were 0.24±0.38, 0.45±0.60, 0.83±0.84, 1.29±1.05 and 1.66±1.66 log10IU/ml, respectively (Figure 1). As expected, the HBsAglevel at week 12 of treatment was not significantly different from that at baseline in this group of patients (t=1.529, P=0.128), while that at week 96 was significantly decreased compared with week 48 (t=2.166, P=0.033).

Conclusion: Prolonged peginterferon α-2a combined with nucleos(t)ide analogue treatment could increase the cumulative HBsAgloss rate. In patients who do not obtain HBsAgloss, prolonged therapy could reduce the HBsAglevel and improve the anti-viral response. The reduction of HBsAglevel of week 12 from baseline could be a predictor of HBsAgclearance
Cancel
8 Answers
Page 1 of 1
Avatar universal
very very important that the most hbsag decrease or response to pegintf+nucs was on 49-96weeks

this means the routine treatment of 48weeks is wrong, another study also showed that the max effect on immune system by pegintf is after 48weeks
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
another consideration: sequential treatment response is still the best even at 48weeks combo add on

pgintf+nucs 120weeks 29.61% hbsag loss
nucs long term 3-7years and then pegintf add on 48weeks 50% hbsag loss
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
I was told NO many times to my requests for this type of treatment. They are butchering us here. :(  only damn nucs is all they prescribe.

Listen to this what I am told. That they dont give interferon to people with undetectable DNA apparently according to US standards that insurance companies have in place for them.
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
I sure would like to see gamma interferon results. In comparison to this.
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
1024307 tn?1292002086
nucs long term 3-7years and then pegintf add on 48weeks 50% hbsag loss



This is something!
Is the 50% HBsAg loss in both cases: HBeAg positive and negative?
50% -that's high.
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal

yes
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
i mean after 3-7years on nucs you get hbeag negative anyway....
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Avatar universal
and the point is not hbeag, it doesn t matter, it is hbsag decline that matters
Comment
Cancel
Comment
Avatar universal
Comment
Comment
Submit Comment
Your Answer
Avatar universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources
Top Hepatitis Answerers
Avatar m tn
Blank
stef2011
Italy
Avatar m tn
Blank
StephenCastlecrag
Australia
Avatar f tn
Blank
Royal36
Avatar m tn
Blank
Liverpatient
Avatar f tn
Blank
flyinsky
paris, France
Avatar m tn
Blank
studyforhope
Other